LHX3 is a crucial transcription factor belonging to the LIM homeobox family, playing an essential role in the development and differentiation of the pituitary gland and the nervous system. As a gene regulatory protein, LHX3 binds to DNA and controls the transcription of various genes pivotal for cell fate and organogenesis. The expression of LHX3 is a tightly regulated process, influenced by numerous intracellular signaling pathways and extracellular cues. Given its significance in development, understanding the mechanisms and agents that can induce the expression of LHX3 is of substantial interest in the field of developmental biology and genetics.
Certain chemical compounds have been identified that could potentially serve as activators of LHX3 expression. Retinoic acid, a metabolite of vitamin A, is known for its role in gene expression during embryonic development and may increase LHX3 levels by binding to retinoic acid receptors, which in turn interact with DNA at specific regulatory regions. Similarly, forskolin is another agent that could potentially elevate LHX3 expression by increasing intracellular cyclic AMP, triggering a cascade that activates CREB transcription factors, known to enhance the transcription of various genes. Compounds like 5-Azacytidine and Trichostatin A are epigenetic modifiers that may upregulate LHX3 expression by altering DNA methylation and histone acetylation, respectively, thus changing the chromatin landscape to favor gene transcription. Additionally, phytochemicals such as epigallocatechin gallate, found in green tea, might also affect LHX3 transcription levels through their roles in modulating epigenetic marks. Hormonal molecules like beta-estradiol could potentially induce LHX3 by binding to their specific receptors, which may interact with the gene's promoter region. Moreover, activators of intracellular signaling cascades, such as Phorbol 12-myristate 13-acetate (PMA) that activates protein kinase C, could also lead to increased transcription of LHX3 by modifying the activity of downstream transcription factors. Understanding how these diverse chemicals can induce LHX3 expression provides valuable insights into the intricate regulation of gene networks that govern developmental processes. It underscores the complex interplay between various biochemical pathways and the gene regulatory frameworks that orchestrate cellular function and identity.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could upregulate LHX3 expression by serving as a ligand for retinoic acid receptors, which are involved in gene transcription during embryonic development of the pituitary and nervous system. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin may induce LHX3 expression by elevating cyclic AMP levels, which can lead to the activation of CREB transcription factors that bind to the LHX3 promoter region. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may increase LHX3 transcription by causing the demethylation of DNA within the gene's promoter region, thereby enhancing its accessibility to transcriptional machinery. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A has the potential to upregulate LHX3 by inhibiting histone deacetylases, thereby promoting a more relaxed chromatin structure around the LHX3 gene, allowing transcription factors to bind more effectively. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate may upregulate LHX3 by altering the pattern of DNA methylation and histone modifications, which can lead to a more transcriptionally active state of the gene. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone could induce LHX3 expression by activating glucocorticoid receptors that interact with glucocorticoid responsive elements in the promoter regions of various genes, including possibly LHX3. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA may increase LHX3 expression by activating protein kinase C, which in turn may enhance the activity of transcription factors that elevate LHX3 gene transcription. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride has the potential to increase LHX3 expression by inhibiting GSK-3, a negative regulator in the Wnt signaling pathway, which when inhibited, can lead to the activation of gene transcription. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Beta-estradiol may upregulate LHX3 by binding to estrogen receptors that can interact with estrogen response elements on the LHX3 gene promoter, enhancing its transcription. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate could lead to an increase in LHX3 expression by inhibiting histone deacetylase, resulting in hyperacetylated histones and a subsequent increase in gene transcription. | ||||||